InvestorsHub Logo
icon url

dr_lowenstein

10/23/15 12:32 AM

#33744 RE: guti #33743

the share price is funny in light of the nonstop promotion of the company. The company has 'magical' technology, Pierce is a god, EP/is needed for every cancer and every immunotherapy drug approved and in development. The UCSF trial is pivotal and the interim analysis will be unveiled in Sept 2014 (oops), the trial will be stopped early so that EP/IL-12 can be commericialized. EP/IL-12 alone is better than Keytruda. UCSF will want to commercialize the product (hmmmm I thought UCSF was a university) and on and on